NO995532L - Nye mellomprodukter og fremgangsmåte for fremstilling derav - Google Patents

Nye mellomprodukter og fremgangsmåte for fremstilling derav

Info

Publication number
NO995532L
NO995532L NO995532A NO995532A NO995532L NO 995532 L NO995532 L NO 995532L NO 995532 A NO995532 A NO 995532A NO 995532 A NO995532 A NO 995532A NO 995532 L NO995532 L NO 995532L
Authority
NO
Norway
Prior art keywords
preparation
processes
new intermediates
general formula
vii
Prior art date
Application number
NO995532A
Other languages
English (en)
Other versions
NO324039B1 (no
NO995532D0 (no
Inventor
Msria Bakonyi
Marianna Csatsrine Nagy
Leventene Molnsr
Zoltsn Makovi
Piroska Jobb
Tiborne Bai
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO995532D0 publication Critical patent/NO995532D0/no
Publication of NO995532L publication Critical patent/NO995532L/no
Publication of NO324039B1 publication Critical patent/NO324039B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Press Drives And Press Lines (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO19995532A 1997-05-13 1999-11-12 Nye mellomprodukter og fremgangsmate for fremstilling derav NO324039B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700884A HU225503B1 (en) 1997-05-13 1997-05-13 Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them
PCT/HU1998/000047 WO1998051681A1 (en) 1997-05-13 1998-05-11 New intermediates and process for the preparation thereof

Publications (3)

Publication Number Publication Date
NO995532D0 NO995532D0 (no) 1999-11-12
NO995532L true NO995532L (no) 1999-12-13
NO324039B1 NO324039B1 (no) 2007-07-30

Family

ID=89995117

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995532A NO324039B1 (no) 1997-05-13 1999-11-12 Nye mellomprodukter og fremgangsmate for fremstilling derav

Country Status (13)

Country Link
US (1) US6258961B1 (no)
EP (1) EP0981524B1 (no)
JP (1) JP4282770B2 (no)
AT (1) ATE238294T1 (no)
AU (1) AU7444798A (no)
BR (1) BR9809111B1 (no)
CA (1) CA2289545C (no)
DE (1) DE69813792T2 (no)
ES (1) ES2195335T3 (no)
HU (1) HU225503B1 (no)
NO (1) NO324039B1 (no)
PT (1) PT981524E (no)
WO (1) WO1998051681A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226421B1 (en) 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
GB0125708D0 (en) * 2001-10-26 2001-12-19 Generics Uk Ltd Novel compounds and processes
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
AU2003238664A1 (en) 2003-03-12 2004-09-30 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
US6858734B2 (en) * 2003-04-23 2005-02-22 Rhodia Pharma Solutions Inc. Preparation of (S)-Clopidogrel and related compounds
WO2004108665A2 (en) * 2003-04-24 2004-12-16 Sun Pharmaceutical Industries Limited A process for preparation of clopidogrel
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
ATE455778T1 (de) 2003-11-03 2010-02-15 Cadila Healthcare Ltd Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
EP1589019B1 (de) * 2004-04-20 2008-08-13 Ratiopharm GmbH Stereoselektives Verfahren zur Herstellung von Clopidogrel
EP1704152A2 (en) * 2004-09-21 2006-09-27 Teva Pharmaceutical Industries Ltd Crystalline clopidogrel hydrobromide and processes for preparation thereof
US20060223845A1 (en) * 2005-02-24 2006-10-05 Eran Turgeman Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
WO2007125544A2 (en) * 2006-04-27 2007-11-08 Ind-Swift Laboratories Limited Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate
KR20080055860A (ko) * 2006-08-03 2008-06-19 테바 파마슈티컬 인더스트리즈 리미티드 클로피도그렐 바이설페이트의 제조 방법
PL382055A1 (pl) * 2007-03-23 2008-09-29 Koźluk Tomasz Nobilus Ent Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
CN102186858A (zh) * 2008-10-24 2011-09-14 桑多斯股份公司 制备s-氯吡格雷的方法
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN103483356B (zh) * 2013-09-30 2016-01-13 浙江美诺华药物化学有限公司 一种（s）-氯吡格雷的硫酸盐或盐酸盐的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
HU225503B1 (en) 2007-01-29
JP2001525818A (ja) 2001-12-11
ES2195335T3 (es) 2003-12-01
EP0981524A1 (en) 2000-03-01
CA2289545A1 (en) 1998-11-19
DE69813792D1 (de) 2003-05-28
ATE238294T1 (de) 2003-05-15
DE69813792T2 (de) 2004-01-29
WO1998051681A1 (en) 1998-11-19
BR9809111A (pt) 2000-08-01
BR9809111B1 (pt) 2009-05-05
US6258961B1 (en) 2001-07-10
NO324039B1 (no) 2007-07-30
HUP9700884A3 (en) 2000-06-28
HUP9700884A2 (hu) 1999-09-28
PT981524E (pt) 2003-08-29
HU9700884D0 (en) 1997-07-28
EP0981524B1 (en) 2003-04-23
JP4282770B2 (ja) 2009-06-24
NO995532D0 (no) 1999-11-12
AU7444798A (en) 1998-12-08
CA2289545C (en) 2006-12-12

Similar Documents

Publication Publication Date Title
NO995532L (no) Nye mellomprodukter og fremgangsmåte for fremstilling derav
NO995531L (no) Nye mellomprodukter og fremgangsmåte for fremstilling derav
EA200001102A1 (ru) Способ синтеза ингибиторов сох-2 (циклооксигеназы-2)
DE69530993D1 (de) Multikatalytische protease-inhibitoren
EA200300925A1 (ru) Новый способ промышленного синтеза ранелата стронция и его гидратов
NO984344L (no) Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analoger
DK1404642T3 (da) Fremgangsmåde til fremstillimg af 7-amino-syn-3,5-dihydroxyheptansyrederivater, mellemprodukter derfor og fremgangsmåder til deres fremstilling
DK0975601T3 (da) Fremgangsmåde til fremstilling af butylthio-isoquinolin og mellemprodukter derfor
FI960206A0 (fi) Menetelmä HIV-proteaasi-inhibiittoreiden valmistamiseksi
MXPA03002493A (es) Proceso eficiente para preparacion de un inhibidor del factor xa.
SE9700706D0 (sv) Process for the preparation of benzothiazoline compounds
ATE225363T1 (de) Synthese von morphin-6-glucuronid
DK1023292T3 (da) Fremgangsmåde til syntese af chlorpurinintermediater
ATE226585T1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
ES2192324T3 (es) Procedimiento para preparar una feniltiobutil-isoquinolina y sus intermedios.
ES2188222T3 (es) Sintesis enantioselectiva.
IT8548935A0 (it) Procedimento di sintesi industriale della n-[1'-allil-2'-pirrolidinil)metil]-2-metossi-4,5-azimmidobenzammide
DK0675880T3 (da) Quinolondisulfider som mellemprodukter
NO993650L (no) Nye forbindelser med hemoregulerende effekt
DK1070082T3 (da) Fremgangsmåde til fremstilling af 4,4-dimethyl-5alfa-cholesta-8,14,24-trien-3beta-ol og mellemprodukter i fremgangsmåden (I)
ES2195122T3 (es) Inhibidores de metaloproteinasa.
TH26544A (th) อนุพันธ์กรด -4 - อัลคิลไทโอ -ไพรมิดิน -5 - อิล อาซีติก

Legal Events

Date Code Title Description
MK1K Patent expired